News
Media
Conferences
Publications
CME/CE
Resources
Subscribe
About
Partnerships

|Videos|May 14, 2021

Addressing Uterine Fibroids with Patient-Physician Collaboration

Author(s)Angie DeRosa, Lindsey Carr, Editor

Senior editor Angie DeRosa interviewed Sateria Venable, Founder & CEO of the Fibroid Foundation, and Ayman Al-Hendy, MD, a professor of ob/gyn at the University of Chicago Medical Center, about patient-physician collaboration when it comes to addressing uterine fibroids.

Newsletter

Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.

Related Content

Long-term cardiovascular disease risk increased in women diagnosed with uterine fibroids | Image Credit: © abhijith3747 - stock.adobe.com.

Long-term cardiovascular disease risk increased in women diagnosed with uterine fibroids

ByMorgan Ebert, Managing Editor

December 10th 2025

Special Report: Managing vasomotor symptoms in menopause | Image credit: Contemporary OB/GYN

Special Report: Future research outlook

ByJoAnn V. Pinkerton, MD,Jill Liss, MD, MSCP, FACOG

October 27th 2025

Special Report: Managing vasomotor symptoms in menopause | Image credit: Contemporary OB/GYN

Special Report: Positioning emerging treatments relative to established options

ByJoAnn V. Pinkerton, MD,Jill Liss, MD, MSCP, FACOG

October 27th 2025

Special Report: Managing vasomotor symptoms in menopause | Image credit: Contemporary OB/GYN

Special Report: How neurokinin receptor antagonists are reshaping the VMS treatment landscape

ByJoAnn V. Pinkerton, MD,Jill Liss, MD, MSCP, FACOG

October 27th 2025

Special Report: Managing vasomotor symptoms in menopause | Image credit: Contemporary OB/GYN

Special Report: Recent advancements in pharmacologic and nonpharmacologic treatment options

ByJoAnn V. Pinkerton, MD,Jill Liss, MD, MSCP, FACOG

October 27th 2025

Latest CME

Expert Illustrations and Commentaries™: Visualizing Glucocorticoid Receptor Modulation in Platinum-Resistant Ovarian Cancer—Looking at Novel Pathways With an Eye Toward the Future of Treatment

Expert Illustrations and Commentaries™: Visualizing Glucocorticoid Receptor Modulation in Platinum-Resistant Ovarian Cancer—Looking at Novel Pathways With an Eye Toward the Future of Treatment

Rachel N. Grisham, MD; Domenica Lorusso, MD, PhD

Community Practice Connections™: Optimizing Treatment Outcomes and Preserving Fertility in Premenopausal HR+ Breast Cancer

Community Practice Connections™: Optimizing Treatment Outcomes and Preserving Fertility in Premenopausal HR+ Breast Cancer

Rebecca Shatsky, MD; Kelly McCann, MD, PhD; Michelle L. Taylor, ANP-BC

Show Me Your Care Plan!™ Insights for Oncology Nurses: Integrating Recent Developments to Improve Outcomes for Patients With Platinum-Resistant Ovarian Cancer

Show Me Your Care Plan!™ Insights for Oncology Nurses: Integrating Recent Developments to Improve Outcomes for Patients With Platinum-Resistant Ovarian Cancer

Ritu Salani, MD, MBA; Jill Alldredge, MD; Emely Alfaro, MS, RN, CNS, OCN

Show Me Your Care Plan!™ Insights for Oncology Nurses: Integrating Recent Developments to Improve Outcomes for Patients with Platinum-Resistant Ovarian Cancer

Show Me Your Care Plan!™ Insights for Oncology Nurses: Integrating Recent Developments to Improve Outcomes for Patients with Platinum-Resistant Ovarian Cancer

Ritu Salani, MD, MBA; Emely Alfaro, MS, RN, CNS, OCN; Jill Alldredge, MD

Addressing Healthcare Inequities: Detecting and Managing the Uncommon – Hemophilia in Women

Addressing Healthcare Inequities: Detecting and Managing the Uncommon – Hemophilia in Women

Danielle Nance, MD; Kimberley Youkhana, MD

Trending on Contemporary OB/GYN

DARE to PLAY sildenafil cream becomes commercially available for women in select states

FDA approves zoliflodacin (Nuzolvence) for uncomplicated gonorrhea

Edward Hook, MD, discusses FDA approval of oral zoliflodacin for uncomplicated gonorrhea

George L. Maxwell, MD, discusses phase 3 SUNFLOWER trial to evaluate Mirena for nonatypical endometrial hyperplasia

Contemporary OB/GYN week in review: HPV vaccine, postpartum depression, and more

© 2025 MJH Life Sciences^®

All rights reserved.